tiprankstipranks
iTeos Therapeutics (ITOS)
NASDAQ:ITOS
US Market
Holding ITOS?
Track your performance easily

iTeos Therapeutics (ITOS) Financial Statements

175 Followers

iTeos Therapeutics Financial Overview

iTeos Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.149; its P/E ratio is -2.49; iTeos Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-1.05. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-$ 35.00M---
Gross Profit-$ 35.00M---
EBIT$ -43.12M$ -4.87M$ -37.75M$ -37.24M$ -42.23M
EBITDA$ -42.81M$ -4.56M$ -37.45M$ -37.02M$ -42.01M
Net Income Common Stockholders$ -45.36M$ -8.54M$ -38.22M$ -30.55M$ -32.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 488.71M$ 571.26M$ 449.14M$ 531.92M$ 599.03M
Total Assets$ 723.08M$ 751.84M$ 629.77M$ 667.59M$ 677.64M
Total Debt$ 5.53M$ 5.52M$ 5.82M$ 6.06M$ 5.93M
Net Debt$ -483.18M$ -565.74M$ -443.32M$ -525.86M$ -593.10M
Total Liabilities$ 91.39M$ 44.93M$ 88.57M$ 92.36M$ 79.38M
Stockholders Equity$ 631.69M$ 663.88M$ 541.20M$ 575.23M$ 598.26M
Cash Flow-
Free Cash Flow$ -37.45M$ -34.37M$ -33.34M$ -15.16M$ -34.64M
Operating Cash Flow$ -37.35M$ -33.93M$ -32.40M$ -13.77M$ -33.89M
Investing Cash Flow$ -91.49M$ 16.32M$ -69.60M$ 61.56M$ 22.69M
Financing Cash Flow$ -442.00K$ 122.38M$ 22.00K$ 307.00K$ 10.00K
Currency in USD

iTeos Therapeutics Earnings and Revenue History

iTeos Therapeutics Debt to Assets

iTeos Therapeutics Cash Flow

iTeos Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis